Novo Nordisk A/S (NONOF)
47.00
+0.19
(+0.41%)
USD |
OTCM |
Aug 24, 16:00
Novo Nordisk Price : 47.00 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 47.90 | 47.90 | 46.60 | 47.00 | 82821.00 |
| Aug 21, 2026 | 46.74 | 47.46 | 46.38 | 46.81 | 655220.0 |
| Aug 20, 2026 | 47.69 | 47.69 | 45.51 | 46.33 | 86988.00 |
| Aug 19, 2026 | 47.30 | 47.30 | 44.97 | 45.40 | 4281.00 |
| Aug 18, 2026 | 43.15 | 45.55 | 43.15 | 44.92 | 47644.00 |
| Aug 17, 2026 | 45.98 | 45.98 | 44.50 | 45.11 | 3632.00 |
| Aug 14, 2026 | 47.00 | 47.19 | 43.67 | 45.14 | 4545.00 |
| Aug 13, 2026 | 45.45 | 47.00 | 44.95 | 45.79 | 3832.00 |
| Aug 12, 2026 | 43.59 | 46.68 | 43.36 | 45.71 | 4461.00 |
| Aug 11, 2026 | 48.37 | 48.37 | 46.91 | 46.91 | 1.503M |
| Aug 10, 2026 | 47.32 | 47.54 | 46.71 | 47.26 | 5772.00 |
| Aug 07, 2026 | 48.87 | 48.87 | 44.83 | 47.08 | 3907.00 |
| Aug 06, 2026 | 46.00 | 46.24 | 43.55 | 45.32 | 4814.00 |
| Aug 05, 2026 | 44.40 | 45.80 | 42.32 | 44.80 | 67373.00 |
| Aug 04, 2026 | 45.11 | 48.39 | 43.11 | 44.50 | 3788.00 |
| Aug 03, 2026 | 46.99 | 47.02 | 45.20 | 45.83 | 7879.00 |
| Jul 31, 2026 | 47.41 | 48.32 | 44.94 | 46.00 | 6088.00 |
| Jul 30, 2026 | 49.94 | 51.42 | 49.80 | 49.80 | 6248.00 |
| Jul 29, 2026 | 51.90 | 52.50 | 50.00 | 50.52 | 3990.00 |
| Jul 28, 2026 | 50.77 | 51.79 | 48.88 | 50.00 | 3025.00 |
| Jul 27, 2026 | 48.38 | 50.68 | 46.72 | 49.13 | 5063.00 |
| Jul 24, 2026 | 46.41 | 50.00 | 46.41 | 49.70 | 48351.00 |
| Jul 23, 2026 | 45.92 | 49.43 | 45.92 | 48.62 | 4555.00 |
| Jul 22, 2026 | 46.99 | 49.49 | 46.99 | 48.49 | 2820.00 |
| Jul 21, 2026 | 50.15 | 50.50 | 48.71 | 49.79 | 3966.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1230.00 |
| ALK-Abello A/S | 37.92 |
| H. Lundbeck A/S | 6.64 |
| Dr. Reddy's Laboratories Ltd. | 12.34 |
| Neumora Therapeutics, Inc. | 1.485 |
Price Related Metrics
| PE Ratio | 11.49 |
| PS Ratio | 4.061 |
| PEG Ratio | 0.9116 |
| Price to Book Value | 6.139 |
| Price to Free Cash Flow | 28.35 |
| Earnings Yield | 8.71% |
| Market Cap | 207.78B |
| PEGY Ratio | 0.699 |
| Operating PE Ratio | 8.950 |
| Normalized PE Ratio | 11.04 |